Methylparaben

Methylparaben

SCHEMBL48756

COC(=O)c1ccc([O-])cc1.[Na+]

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Methylparaben. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 known ✓ P00915 6/20 0.61
CA2 known ✓ P00918 6/20 0.61
CA12 known ✓ O43570 4/20 0.61
XDH known ✓ P47989 1/20 0.50
CA9 Q16790 4/20 0.61
CA14 Q9ULX7 4/20 0.61
CA7 P43166 2/20 0.61
TDP1 Q9NUW8 1/20 0.61
TSHR P16473 1/20 0.58
MAPT P10636 4/20 0.55
ALDH1A1 P00352 2/20 0.55
LOXL2 Q9Y4K0 1/20 0.53
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
CASP3 P42574 1/20 0.50
RAB9A P51151 1/20 0.50
SENP8 Q96LD8 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
SENP6 Q9GZR1 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylparaben SCHEMBL2810863 0.95 CA1 (0.61) CA1CA2CA12CA9CA14
Methylparaben SCHEMBL475868 0.95 CA1 (0.61) CA1CA2CA12CA9CA14
Methylparaben SCHEMBL5899662 0.86 TSHR (0.63) CA1CA2CA12CA9CA14
SCHEMBL28993944 0.85 CA1 (0.80) CA1CA2CA12CA9CA14
SCHEMBL23600 0.85 CA1 (0.80) CA1CA2CA12CA9CA14
Propylparaben SCHEMBL7607113 0.84 ALDH1A1 (0.60) TDP1TSHRMAPTALDH1A1MEN1
Methylparaben SCHEMBL27781967 0.83 CA1 (0.69) CA1CA2CA12CA9CA14
SCHEMBL28704033 0.83 CA1 (0.76) CA1CA2CA12CA9CA14
Water SCHEMBL22720573 0.83 CA1 (0.76) CA1CA2CA12CA9CA14
SCHEMBL28993277 0.83 CA1 (0.76) CA1CA2CA12CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4754 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743053-A1 ANTIMICROBIAL SYNERGIES Symrise AG (DE) 2026-05-20 EP claimed
WO-2026099342-A1 ORAL CARE COMPOSITION FOR USE IN THE TREATMENT OF DRY MOUTH ORAL CARE SOLUTIONS GMBH (CH) 2026-05-15 WO claimed
EP-4740931-A1 ORAL CARE COMPOSITION FOR USE IN THE TREATMENT OF DRY MOUTH Oral Care Solutions GmbH (CH) 2026-05-13 EP claimed
US-20260124120-A1 STABILIZED AQUEOUS COMPOSITIONS CONTAINING HYDROXYAPTITE AND FREE IONS FOR IN VIVO REMINERALIZATION OF CALCIFIED TISSUE & THEIR METHODS OF USE INTER MED INC (US) 2026-05-07 US claimed
WO-2026090627-A1 STABLE PITOLISANT LIQUID FORMULATIONS AND METHOD OF ITS USE PATEL SANDIPKUMAR (US) 2026-04-30 WO claimed
US-12595237-B2 Lamotrigine hydrate crystal form, preparation method therefor, and composition containing same SHANGHAI AUCTA PHARMACEUTICALS CO., LTD. (CN) 2026-04-07 US claimed
US-20260069570-A1 STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE SLAYBACK PHARMA LLC (US) 2026-03-12 US claimed
EP-4554551-B1 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS SYMRISE AG (DE) 2026-03-11 EP claimed
US-20260041094-A1 Compositions Comprising an Antimicrobial Boosting Agent SYMRISE AG (DE) 2026-02-12 US claimed
US-12491178-B2 Stable pharmaceutical compositions of edaravone SLAYBACK PHARMA LLC (US) 2025-12-09 US claimed
EP-1121105-A1 PROPOFOL-BASED ANESTHETIC AND METHOD OF MAKING SAME Phoenix Scientific, Inc. (US) 2001-08-08 EP claimed
WO-2001032795-A1 CYANOACRYLATE SOLUTIONS CONTAINING PRESERVATIVES CLOSURE MEDICAL CORPORATION (US) 2001-05-10 WO claimed
EP-1058535-A1 DESENSITIZING DENTAL COMPOSITION Italmed S.N.C. Di Galli G. E Pacini G. (IT) 2000-12-13 EP claimed
WO-2000071175-A1 OPHTHALMIC SOLUTIONS INCORPORATING AN ANTIMICROBIAL POLYPEPTIDE LARGE SCALE BIOLOGY CORPORATION (US) 2000-11-30 WO claimed
WO-2000021517-A1 PROPOFOL-BASED ANESTHETIC AND METHOD OF MAKING SAME PHOENIX SCIENTIFIC, INC. (US) 2000-04-20 WO claimed
WO-2000008061-A1 REACTION PRODUCTS OF HYALURONIC ACID AND NATURAL AMINO ACIDS AND THEIR USE IN COSMETIC AND PHARMACEUTICAL COMPOSITIONS JASPER LTD. LIABILITY CO. (US) 2000-02-17 WO claimed
EP-0971696-A1 THIMEROSAL-FREE PRESERVATIVES FOR VACCINES Merck & Co., Inc. (US) 2000-01-19 EP claimed
WO-1999044570-A1 DESENSITIZING DENTAL COMPOSITION ITALMED S.N.C. DI GALLI G. E PACINI G. (IT) 1999-09-10 WO claimed
WO-1998034594-A1 THIMEROSAL-FREE PRESERVATIVES FOR VACCINES MERCK & CO., INC. (US) 1998-08-13 WO claimed
EP-0489217-A1 Calcitonin compositions for intranasal administration DR. A. TOSI FARMACEUTICI S.R.L. (IT) 1992-06-10 EP claimed